英文名稱 |
中文名稱 |
CAS號 |
操作 |
AMC-01 |
化合物 T29955 |
1047978-71-1 |
詳細(xì)
|
Saripidem |
沙立吡旦 |
103844-86-6 |
詳細(xì)
|
L 888607 Racemate |
1030017-51-6 |
1030017-51-6 |
詳細(xì)
|
Cnidimol B |
103629-81-8 |
103629-81-8 |
詳細(xì)
|
(S)-9-((tert-Butyldimethylsilyl)oxy)-4,11-diethyl-4-hydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione |
(4S)-9-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-4,11-diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione |
1023758-14-6 |
詳細(xì)
|
A-935142 |
A-935142 |
1031335-85-9 |
詳細(xì)
|
Namirotene |
那米羅汀 |
101506-83-6 |
詳細(xì)
|
GSK3a-IN-38 |
3,7,7-三甲基-4-吡啶-4-基-6,7,8,9-四氫吡唑并[1,3-B]喹啉-4(5H)酮 |
1062138-03-7 |
詳細(xì)
|
Gevotroline |
吉伏曲林 |
107266-06-8 |
詳細(xì)
|
Minamestane |
米那美坦 |
105051-87-4 |
詳細(xì)
|
Monatepil maleate |
MONATEPIL 馬來酸鹽 |
103379-03-9 |
詳細(xì)
|
PP5-IN-1 |
PP5抑制劑1 |
1022417-69-1 |
詳細(xì)
|
Luciferase-IN-1 |
(4-Benzothiazol-2-yl-phenyl)-dimethyl-amine |
10205-56-8 |
詳細(xì)
|
Ainsliadimer A |
化合物 AINSLIADIMER A |
1039431-94-1 |
詳細(xì)
|
Lorvotuzumab mertansine |
Lorvotuzumab Mertansine |
1008106-64-6 |
詳細(xì)
|
Icrucumab |
ICRUCUMAB ( 艾蘆庫單抗 ) |
1024603-92-6 |
詳細(xì)
|
ROCK2-IN-10 |
ROCK2 抑制劑 10 |
1072906-07-0 |
詳細(xì)
|
Antidepressantagent5 |
抗抑郁劑5 |
1071049-42-7 |
詳細(xì)
|
Gizzerosine HCl |
化合物 GIZZEROSINE 2HCL |
103548-49-8 |
詳細(xì)
|
GSK2324 |
GSK-2324 |
1020567-30-9 |
詳細(xì)
|
BAY 60-2770 |
BAY 60-2770
(BAY 602770) |
1027642-43-8 |
詳細(xì)
|
Aloenin B |
蘆薈寧B |
106533-41-9 |
詳細(xì)
|
PA3552-IN-1 |
化合物 PA3552-IN-1 |
1008121-12-7 |
詳細(xì)
|
Xanthine oxidoreductase-IN-4 |
N-(4-乙氧基苯基)-4-(1H-四唑-5-基)苯甲酰胺 |
1026587-58-5 |
詳細(xì)
|
Sabeluzole |
化合物 T28655 |
104383-17-7 |
詳細(xì)
|
(3aR,9aR)-Fluparoxan |
化合物(3AR, 9AR)-FLUPAROXAN |
105182-47-6 |
詳細(xì)
|
MK-6186 |
MK-6186 |
1034474-19-5 |
詳細(xì)
|
IDX184 |
2'-C-甲基鳥苷 5'-[2-[(3-羥基-2,2-二甲基-1-氧代丙基)硫基]乙基 N-(苯基甲基)氨基磷酸酯] |
1036915-08-8 |
詳細(xì)
|
Samalizumab |
Samalizumab |
1073059-33-2 |
詳細(xì)
|
Pidilizumab |
Pidilizumab |
1036730-42-3 |
詳細(xì)
|
Cholesteryl Hemisuccinate Tris Salt |
膽甾醇琥珀酸酯 |
102601-49-0 |
詳細(xì)
|
IXA6 |
化合物 IXA6 |
1021106-40-0 |
詳細(xì)
|
Nanterinone |
南力農(nóng) |
102791-47-9 |
詳細(xì)
|
Zanoterone |
扎諾特隆 |
107000-34-0 |
詳細(xì)
|
PARP10-IN-2 |
化合物PARP10-IN-2 |
1042780-52-8 |
詳細(xì)
|
CTP |
心臟靶向肽CTP |
1052692-86-0 |
詳細(xì)
|
Sonepcizumab |
SONEPCIZUMAB (ANTI-SPHINGOSINE-1-PHOSPHATE) |
1031360-18-5 |
詳細(xì)
|
Binospirone |
比螺酮 |
102908-59-8 |
詳細(xì)
|
KS370G |
2-PropenaMide, 3-(3,4-dihydroxyphenyl)-N-(2-phenylethyl)- |
105955-01-9 |
詳細(xì)
|
3-Hydroxy agomelatine D3 |
3-Hydroxy Agomelatine D3 |
1079774-23-4 |
詳細(xì)
|
ZINC12409120 |
化合物 ZINC12409120 |
1010888-06-8 |
詳細(xì)
|
Carbonic anhydrase inhibitor 6 |
化合物 CARBONIC ANHYDRASE INHIBITOR 6 |
1013213-84-7 |
詳細(xì)
|
Glu-urea-Lys |
多肽GLU-UREA-LYS |
1025796-69-3 |
詳細(xì)
|
NSC 694621 |
化合物 ISOTHIAZOLO[5,4-B]PYRIDIN-3(2H)-ONE, 2-(4-METHOXYPHENYL)- |
104857-29-6 |
詳細(xì)
|
Xanthine oxidoreductase-IN-5 |
化合物T72166 |
1026652-90-3 |
詳細(xì)
|
Pobilukast |
泊比司特 |
107023-41-6 |
詳細(xì)
|
Setrobuvir |
N-[3-[(4AR,5S,8R,8AS)-1-[(4-氟苯基)甲基]-1,2,4A,5,6,7,8,8A-八氫-4-羥基-2-氧代-5,8-甲橋喹啉-3-基]-1,1-二氧代-2H-1,2,4-苯并噻二嗪-7-基]甲磺酰胺 |
1071517-39-9 |
詳細(xì)
|
Antroquinonol |
化合物 T30087 |
1010081-09-0 |
詳細(xì)
|
AR453588 |
AR453588 |
1065609-00-8 |
詳細(xì)
|
Etrolizumab |
ETROLIZUMAB ( 依曲利組單抗 ) |
1044758-60-2 |
詳細(xì)
|
DLinDAP |
化合物 T31546 |
1019000-51-1 |
詳細(xì)
|
CC214-1 |
化合物 CC214-1 |
1021920-32-0 |
詳細(xì)
|
R 56865 |
R 56865 |
104606-13-5 |
詳細(xì)
|
YM 16638 |
YM 16638 |
104073-72-5 |
詳細(xì)
|
SB-429201 |
SB-429201 |
1027971-34-1 |
詳細(xì)
|
SF2312 |
SF 2312(SF2312) |
107729-45-3 |
詳細(xì)
|
MCC |
滅草靈 |
104676-09-7 |
詳細(xì)
|
Tralokinumab |
曲羅蘆單抗 |
1044515-88-9 |
詳細(xì)
|
(+)-Yashabushidiol B |
(3R,5R)-1,7-DIPHENYLHEPTANE-3,5-DIOL |
103729-38-0 |
詳細(xì)
|
Dextromethorphan-d3 |
右美沙芬-D3 |
1079043-53-0 |
詳細(xì)
|
(Rac)-PF-998425 |
(RAC)-PF-998425 |
1076225-26-7 |
詳細(xì)
|
Saterinone |
沙特力農(nóng) |
102669-89-6 |
詳細(xì)
|
RG 7152 |
RG 7152 |
107813-63-8 |
詳細(xì)
|
(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-7,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid |
(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-三羥基-7,10,13-三甲基十六氫-1H-環(huán)戊二烯并[A]菲-17-基)戊酸 |
102362-49-2 |
詳細(xì)
|
SQLE-IN-1 |
SQLE 抑制劑1 |
1019169-83-5 |
詳細(xì)
|
Tivicilovir |
化合物 TIVICILOVIR |
103024-93-7 |
詳細(xì)
|
1-O-p-Coumaroylglycerol |
1-O-對香豆?;视?/td>
| 106055-11-2 |
詳細(xì)
|
Pazinaclone |
帕秦克隆 |
103255-66-9 |
詳細(xì)
|
Flaviviruses-IN-2 |
N-(4-甲氧基苯基)-2-苯基-2-(2-(噻吩-2-基)乙酰胺基)乙酰胺 |
1009762-84-8 |
詳細(xì)
|
KT-362 fumarate |
KT 362 |
105394-80-7 |
詳細(xì)
|
Leminoprazole |
leminoprazole |
104340-86-5 |
詳細(xì)
|
Camonagrel |
卡莫格雷 |
105920-77-2 |
詳細(xì)
|
8-Dehydroxyshanzhiside |
8-去氫山梔苷 |
1008532-71-5 |
詳細(xì)
|
Para Red-d6 (naphthyl-d6) |
(辦證)對位紅D6 |
1014689-16-7 |
詳細(xì)
|
Tafetinib |
化合物 T28911 |
1032265-57-8 |
詳細(xì)
|
TIE-2/VEGFR-2 kinase-IN-5 |
TIE-2/VEGFR-2 KINASE 抑制劑5 |
1014407-83-0 |
詳細(xì)
|
ANATinhibitor-2 |
ANAT?INHIBITOR-2 |
1048244-34-3 |
詳細(xì)
|
ALDH3A1-IN-1 |
化合物 ALDH3A1-IN-1 |
1039855-56-5 |
詳細(xì)
|
Pirimicarb-d6 (dimethylcarbamate-d6) |
抗蚜威-D6 |
1015854-66-6 |
詳細(xì)
|
Teprotumumab |
TEPROTUMUMAB ( 替妥木單抗 ) |
1036734-93-6 |
詳細(xì)
|
Timolumab |
Timolumab |
1073538-99-4 |
詳細(xì)
|
RB-OPD |
RB-OPD |
1034863-51-8 |
詳細(xì)
|
NC-1300-B |
Benzenamine, N,N-dimethyl-2-[[(6-methyl-1H-benzimidazol-2-yl)sulfinyl]methyl]- |
104340-52-5 |
詳細(xì)
|
SN52 |
抑制劑多肽SN52 |
1071173-56-2 |
詳細(xì)
|
NSC 80467 |
NSC 80467 |
101982-51-8 |
詳細(xì)
|
β-catenin modulator IIa-661 |
WAY-332062 |
1015859-04-7 |
詳細(xì)
|
Torbafylline |
托巴茶堿 |
105102-21-4 |
詳細(xì)
|
WIN 54954 |
WIN-54954 |
107355-45-3 |
詳細(xì)
|
Fluparoxan hydrochloride |
無水氟洛克生鹽酸鹽 |
105227-44-9 |
詳細(xì)
|
Gantenerumab |
更汀蘆單抗 |
1043556-46-2 |
詳細(xì)
|
Glembatumumab |
GLEMBATUMUMAB ( 格巴妥木單抗 ) |
1020264-78-1 |
詳細(xì)
|
KDM4-IN-3 |
化合物 KDM4-IN-3 |
1068515-53-6 |
詳細(xì)
|
Mequitamium |
甲喹碘銨 |
101396-46-7 |
詳細(xì)
|
BN82002 hydrochloride |
BN82002 HYDROCHLORIDE |
1049740-43-3 |
詳細(xì)
|
Ecabapide |
依卡派特 |
104775-36-2 |
詳細(xì)
|
Nerisopam |
奈立索泮 |
102771-12-0 |
詳細(xì)
|
Estredox |
化合物 T27287 |
103562-82-9 |
詳細(xì)
|
AZD4694 |
AZD-4694 |
1054629-49-0 |
詳細(xì)
|
Enavatuzumab |
ENAVATUZUMAB ( 依那妥組單抗 ) |
1062149-33-0 |
詳細(xì)
|
BC-7013 |
化合物 T26755 |
1028291-66-8 |
詳細(xì)
|